Geir Hetland joins the board of Oslo Cancer Cluster
The Chief Financial Officer of Thermo Fisher Scientific is the newest board member.
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 283 entries.
The Chief Financial Officer of Thermo Fisher Scientific is the newest board member.
Can home tests engage more people in cancer screening and save more lives?
The Translational Research Unit at the Section for Cellular Therapy based in Norway recently published two groundbreaking studies showcasing the potential of cell-based therapies in combating cancer.
Lytix Biopharma and Curida, both Norwegian-owned, have gained attention and acclaim for their innovative approaches and substantial contributions to the healthcare sector.